1. Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma. Issue 7 (July 2015) Authors: Li, Fei; Hao, Mu; Feng, Xiaoyan; Zang, Meirong; Qin, Yu; Yi, Shuhua; Li, Zengjun; Xu, Yan; Zhou, Lili; Sui, Weiwei; Deng, Shuhui; Zou, Dehui; Zhan, Fenghuang; Qiu, Lugui Journal: Leukemia research Issue: Volume 39:Issue 7(2015:Jul.) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Drug Resistance in Hematologic Malignancies: Induction Mechanisms, Genetics, and Therapeutics. (27th April 2015) Authors: Zhan, Fenghuang; Zangari, Maurizio; Qiu, Lugui Journal: BioMed research international Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Extracellular vesicle expansion of PMIS‐miR‐210 expression inhibits colorectal tumour growth via apoptosis and an XIST/NME1 regulatory mechanism. Issue 9 (18th September 2022) Authors: Eliason, Steven; Hong, Liu; Sweat, Yan; Chalkley, Camille; Cao, Huojun; Liu, Qi; Qi, Hank; Xu, Hongwei; Zhan, Fenghuang; Amendt, Brad A. Journal: Clinical and translational medicine Issue: Volume 12:Issue 9(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma. (12th August 2019) Authors: Gao, Minjie; Bai, Hua; Jethava, Yogesh; Wu, Yujie; Zhu, Yuqi; Yang, Ye; Xia, Jiliang; Cao, Huojun; Franqui-Machin, Reinaldo; Nadiminti, Kalyan; Thomas, Gregory S; Salama, Mohamed E; Altevogt, Peter; Bishop, Gail; Tomasson, Michael; Janz, Siegfried; Shi, Jumei; Chen, Lijuan; Frech, Ivana; Tricot, ... Journal: Journal of the National Cancer Institute Issue: Volume 112:Number 5(2020) Page Start: 507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Inhibition of Nek2 by Small Molecules Affects Proteasome Activity. (16th September 2014) Authors: Meng, Lingyao; Carpenter, Kent; Mollard, Alexis; Vankayalapati, Hariprasad; Warner, Steven L.; Sharma, Sunil; Tricot, Guido; Zhan, Fenghuang; Bearss, David J. Other Names: Zangari Maurizio Academic Editor. Journal: BioMed research international Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Low serum miR‐19a expression as a novel poor prognostic indicator in multiple myeloma. Issue 8 (19th September 2014) Authors: Hao, Mu; Zang, Meirong; Wendlandt, Erik; Xu, Yan; An, Gang; Gong, Dasen; Li, Fei; Qi, Fang; Zhang, Yanru; Yang, Ye; Zhan, Fenghuang; Qiu, Lugui Journal: International journal of cancer Issue: Volume 136:Issue 8(2015:Apr. 15) Page Start: 1835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA. (10th November 2020) Authors: Deshpande, Shayu; Tytarenko, Ruslana G.; Wang, Yan; Boyle, Eileen M.; Ashby, Cody; Schinke, Carolina D.; Thanendrarajan, Sharmilan; Zangari, Maurizio; Zhan, Fenghuang; Davies, Faith E.; Morgan, Gareth J.; van Rhee, Frits; Walker, Brian A. Journal: European journal of haematology Issue: Volume 106:Number 2(2021) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA. (10th November 2020) Authors: Deshpande, Shayu; Tytarenko, Ruslana G.; Wang, Yan; Boyle, Eileen M.; Ashby, Cody; Schinke, Carolina D.; Thanendrarajan, Sharmilan; Zangari, Maurizio; Zhan, Fenghuang; Davies, Faith E.; Morgan, Gareth J.; van Rhee, Frits; Walker, Brian A. Journal: European journal of haematology Issue: Volume 106:Number 2(2021) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. NEK2 induces autophagy‐mediated bortezomib resistance by stabilizing Beclin‐1 in multiple myeloma. Issue 4 (29th January 2020) Authors: Xia, Jiliang; He, Yanjuan; Meng, Bin; Chen, Shilian; Zhang, Jingyu; Wu, Xuan; Zhu, Yinghong; Shen, Yi; Feng, Xiangling; Guan, Yongjun; Kuang, Chunmei; Guo, Jiaojiao; Lei, Qian; Wu, Yangbowen; An, Gang; Li, Guancheng; Qiu, Lugui; Zhan, Fenghuang; Zhou, Wen Journal: Molecular oncology Issue: Volume 14:Issue 4(2020) Page Start: 763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Nek2 Is a Novel Regulator of B Cell Development and Immunological Response. (17th November 2014) Authors: Gu, Zhimin; Zhou, Wen; Huang, Junwei; Yang, Ye; Wendlandt, Erik; Xu, Hongwei; He, Xiao; Tricot, Guido; Zhan, Fenghuang Other Names: Lee Wen-Hwa Academic Editor. Journal: BioMed research international Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗